Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71.68 CAD | +0.97% | -3.35% | +23.09% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.44% | 291B | |
+12.12% | 150B | |
+43.23% | 117B | |
+22.36% | 82.53B | |
+10.59% | 75.79B | |
+20.82% | 62.6B | |
+12.33% | 58.54B | |
+6.93% | 46.61B | |
-5.34% | 36.01B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv : Buy Rating Reiterated at TPH as Target Price Boosted Following Q1 Results